Celebrating Charles Kelman and phacoemulsification.

Dr. Robert Osher introduces this tribute video to Dr. Charles Kelman, originally shown in 2004 after he had passed away.

Celebrating Charles Kelman and phacoemulsification.
Colin Kerr
Colin Kerr
Published: Friday, June 23, 2017
Dr. Robert Osher introduces this tribute video to Dr. Charles Kelman, originally shown in 2004 after he had passed away. The video documents his huge contribution to ophthalmology and celebrates his remarkable life and career. Highlights include: -Early phacoemulsification teaching footage -Some of the first ever ophthalmic live surgeries -His appearances on Late-Night Talk Shows including David Letterman and Johnny Carson -Several high-profile lectures he gave over the years http://player.escrs.org/…/celebrating-charles-kellman-on-th…
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...